Award recordCONTRACT

ABBVIE US LLC

PIID 36C26025F0251· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $68,992 net obligations· UEI MAB9Y43Z1US6· IL

Description

FOSCARBIDOPA 12MG/ML/FOSLEVODOPA 240MG/ML INJ,SOLN - 5 MONTH SUPPLY - INCREASE PRICE & USAGE.

Base award description: FOSCARBIDOPA 12MG/ML/FOSLEVODOPA 240MG/ML INJ,SOLN - 4 MONTH SUPPLY

First action · last action
2025-05-07 · 2025-08-05
Transactions
3
First transaction's obligation
$6,865
Base + all options value (sum of deltas)
$68,992
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0528
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$68,992$0Base award · 2025-05-07 · this action $6,865 · running total $6,865Modification P00001 · 2025-05-21 · this action $61,781 · running total $68,646Modification P00002 · 2025-08-05 · this action $346 · running total $68,992
  • Base2025-05-07+$6,865= $6,865
  • Mod P000012025-05-21+$61,781= $68,646
  • Mod P000022025-08-05+$346= $68,992
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-05-07+$6,865$6,865FOSCARBIDOPA 12MG/ML/FOSLEVODOPA 240MG/ML INJ,SOLN - 4 MONTH SUPPLY
Mod P00001· FUNDING ONLY ACTION2025-05-21+$61,781$68,646FOSCARBIDOPA 12MG/ML/FOSLEVODOPA 240MG/ML INJ,SOLN - 5 MONTH SUPPLY - INCREASE PRICE & USAGE.
Mod P00002· FUNDING ONLY ACTION2025-08-05+$346$68,992FOSCARBIDOPA 12MG/ML/FOSLEVODOPA 240MG/ML INJ,SOLN - 5 MONTH SUPPLY - INCREASE PRICE & USAGE.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MAB9Y43Z1US6)

AwardOffice · PSC / listingNet obligationsFY
36C26226P0366262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$3,317FY2026
36C26226P0330262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$1,432FY2026
36C26226P0199262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$21,573FY2026
36C26026F0020260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$41,534FY2026
36C26026F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$113,265FY2026
36E79725A0024NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26025F0251_3600_36F79718D0528_3600 · retrieved 2026-09-26.